| Stone Creek Psychotherapy | |
|
20915 Kingsland Blvd Katy TX 77450-5548 | |
| (281) 579-0703 | |
| (281) 398-9719 |
| Full Name | Stone Creek Psychotherapy |
|---|---|
| Speciality | Counselor |
| Location | 20915 Kingsland Blvd, Katy, Texas |
| Authorized Official Name and Position | Dianne Wilson Appolito (DIRECTOR/OWNER) |
| Authorized Official Contact | 2815790703 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Stone Creek Psychotherapy 20915 Kingsland Blvd Katy TX 77450-5548 Ph: (281) 579-0703 | Stone Creek Psychotherapy 20915 Kingsland Blvd Katy TX 77450-5548 Ph: (281) 579-0703 |
| NPI Number | 1003009978 |
|---|---|
| Provider Enumeration Date | 08/23/2007 |
| Last Update Date | 08/03/2021 |
| Certification Date | 08/03/2021 |
| Medicare PECOS PAC ID | 7012313414 |
|---|---|
| Medicare Enrollment ID | O20210910000508 |
News Archive
Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme, the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis
The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003009978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 06714 (Texas) | Primary |
| Provider Name | Diane C Schaefer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770993024 PECOS PAC ID: 4082643689 Enrollment ID: I20160920002567 |
News Archive
Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme, the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis
The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
› Verified 6 days ago
| Provider Name | Leticia H White |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770936098 PECOS PAC ID: 1557767969 Enrollment ID: I20210910000993 |
News Archive
Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme, the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis
The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
› Verified 6 days ago
| Provider Name | Stella L Lessert |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1801207709 PECOS PAC ID: 9638576432 Enrollment ID: I20210921002990 |
News Archive
Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme, the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis
The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
› Verified 6 days ago
News Archive
Response Genetics, Inc. today announced that it has entered into an agreement with Special Situations Fund III QP, L.P., Special Situations Cayman Fund L.P, Special Situations Life Sciences Fund, L.P. and certain of their affiliates (collectively, "SSF") to settle SSF's proxy contest.
A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme, the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease's aggressive and invasive nature.
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of follow-up.
Researchers investigated risk factors for the development of opioid dependence in patients undergoing surgery for degenerative spondylolisthesis
The cost of having a baby, from the first prenatal visit to the baby's delivery, averaged roughly $7,600 for an uncomplicated birth, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
› Verified 6 days ago
Valentia-bilingual Therapy Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 722 Pin Oak Rd Ste 220, Katy, TX 77494 Phone: 832-687-5125 | |
Able Thoughts Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1503 Valley Landing Dr., Katy, TX 77450 Phone: 281-827-8556 | |
Liberty Mental Wellness, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 227020 Morton Ranch Rd, Ste 160, #270, Katy, TX 77449 Phone: 832-844-5611 | |
Creative Therapeutic Space, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 23211 Red River Dr, Katy, TX 77494 Phone: 832-779-3201 | |
Catalyst Behavior Solutions Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 21230 Kingsland Blvd Ste 100a, Katy, TX 77450 Phone: 605-271-2690 Fax: 605-271-3956 | |
Edward E Icaza Md Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 23920 Katy Freeway, #405, Katy, TX 77494 Phone: 832-437-8375 Fax: 832-437-2813 |